LEUKOTRIENE RELEASE FROM PERIPHERAL AND PERITONEAL LEUKOCYTES FOLLOWING EXPOSURE TO PERITONEAL-DIALYSIS SOLUTIONS

被引:32
作者
JORRES, A [1 ]
JORRES, D [1 ]
TOPLEY, N [1 ]
GAHL, GM [1 ]
MAHIOUT, A [1 ]
机构
[1] UNIV COLL CARDIFF,ROYAL INFIRM,INST NEPHROL,KIDNEY RES UNIT FDN,CARDIFF CF4 4XN,S GLAM,WALES
关键词
CAPD; PERITONITIS; PERITONEAL DIALYSATE; PMN; LEUKOTRIENES;
D O I
10.1093/ndt/6.7.495
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
During continuous ambulatory peritoneal dialysis (CAPD), peritoneal host defence mechanisms are repeatedly exposed to dialysis solutions (with unphysiological composition) which may compromise peritoneal immune cell functions. In this context, the current study focused on the capacity of peripheral and peritoneal PMN to release leukotrienes following exposure to conventional CAPD dialysates. PMN were obtained from peripheral blood of healthy volunteers and from the peritoneal effluent of CAPD patients with acute peritonitis. Following isolation, cells were incubated in fresh CAPD dialysates or control buffer, and calcium ionophore A23187-stimulated leukotriene synthesis was measured. Additional experiments included RP-HPLC analysis and radioactivity monitoring of lipoxygenase products in PMN labelled with C-14-arachidonic acid. Leukotriene B4 and leukotrienes C4/D4/E4 were determined by radioimmunoassay. Ionophore-triggered leukotriene release from cells exposed to control buffer was pronounced in inflammatory peritoneal PMN (70.4 +/- 31.3 ng/5 x 10(6) cells LTB4 and 13.4 +/- 19.8 ng/5 x 10(6) cells LTC4/D4/E4, mean +/- SD, n = 14) when compared to healthy peripheral PMN (26.6 +/- 16.9 ng/ml LTB4 and 6.3 +/- 6.6 ng/ml LTC4/D4/E4, n = 12). Incubation in fresh solutions for peritoneal dialysis severely depressed leukotriene release from both cell populations. These results indicate a severe inhibition of cellular responsiveness as a consequence of dialysate exposure which could contribute to the impairment of host defence early in the CAPD cycle.
引用
收藏
页码:495 / 501
页数:7
相关论文
共 18 条
[1]  
Alobaidi H M, 1986, Nephrol Dial Transplant, V1, P16
[2]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[3]   THE PHARMACOLOGY AND PATHO-PHYSIOLOGY OF LEUKOTRIENE-B4 [J].
BRAY, MA .
BRITISH MEDICAL BULLETIN, 1983, 39 (03) :249-254
[4]   HUMAN PERITONEAL-MACROPHAGES SYNTHESIZE LEUKOTRIENE-B-4 AND LEUKOTRIENE-C-4 [J].
DU, JT ;
FOEGH, M ;
MADDOX, Y ;
RAMWELL, PW .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 753 (02) :159-163
[5]   EFFECTS OF THE COMPOSITION OF PERITONEAL-DIALYSIS FLUID ON CHEMI-LUMINESCENCE, PHAGOCYTOSIS, AND BACTERICIDAL ACTIVITY INVITRO [J].
DUWE, AK ;
VAS, SI ;
WEATHERHEAD, JW .
INFECTION AND IMMUNITY, 1981, 33 (01) :130-135
[6]   CYTOTOXICITY OF COMMERCIAL PERITONEAL-DIALYSIS SOLUTIONS TOWARDS PERITONEAL-CELLS OF CHRONICALLY UREMIC MICE [J].
GALLIMORE, B ;
GAGNON, RF ;
STEVENSON, MM .
NEPHRON, 1986, 43 (04) :283-289
[7]   INTRAPERITONEAL SECRETION OF INTERLEUKIN-6 DURING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS [J].
GOLDMAN, M ;
VANDENABEELE, P ;
MOULART, J ;
AMRAOUI, Z ;
ABRAMOWICZ, D ;
NORTIER, J ;
VANHERWEGHEM, JL ;
FIERS, W .
NEPHRON, 1990, 56 (03) :277-280
[8]  
HAIN H, 1990, 5TH C INT SOC PER DI
[9]   SUPPRESSION OF NEUTROPHIL SUPEROXIDE PRODUCTION BY CONVENTIONAL PERITONEAL-DIALYSIS SOLUTION [J].
ING, BL ;
GUPTA, DK ;
NAWAB, ZM ;
ZHOU, FQ ;
RAHMAN, MA ;
DAUGIRDAS, JT .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1988, 11 (05) :351-354
[10]  
KEANE WF, 1984, PERITON DIALYSIS B, V4, P122